Cancer in Patients with Rheumatic Diseases Exposed to TNF AntagonistsCARMONA, Loreto; ABASOLO, Lydia; DESCALZO, Miguel A et al.Seminars in arthritis and rheumatism. 2011, Vol 41, Num 1, pp 71-80, issn 0049-0172, 10 p.Article

Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalitiesVAULOUP, Christelle; KRZYSIEK, Roman; GREANGEOT-KEROS, Liliane et al.European cytokine network (Montrouge). 2006, Vol 17, Num 4, pp 290-293, issn 1148-5493, 4 p.Article

Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c⁺ dendritic cells derived from CD34⁺ cells exposed to TNF-αGUO, Yong-Mei; HIROKAWA, Makoto; HEBIGUCHI, Miwa et al.International journal of hematology. 2010, Vol 91, Num 1, pp 61-68, issn 0925-5710, 8 p.Article

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic ReviewCRUZ FERNANDEZ-ESPARTERO, Maria; PEREZ-ZAFRILLA, Beatriz; NARANJO, Antonio et al.Seminars in arthritis and rheumatism. 2011, Vol 40, Num 4, pp 330-337, issn 0049-0172, 8 p.Article

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic ReviewFERNANDEZ-ESPARTERO, Maria Cruz; PEREZ-ZAFRILLA, Beatriz; NARANJO, Antonio et al.Seminars in arthritis and rheumatism. 2011, Vol 41, Num 3, pp 524-533, issn 0049-0172, 10 p.Article

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression?SOCZYNSKA, Joanna K; KENNEDY, Sidney H; GOLDSTEIN, Benjamin I et al.Neurotoxicology (Park Forest South). 2009, Vol 30, Num 4, pp 497-521, issn 0161-813X, 25 p.Article

Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisalsKIELY, Patrick D. W; DEIGHTON, Chris; DIXEY, Josh et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 1, pp 24-31, issn 1462-0324, 8 p.Article

Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescentHESS, Steffen; HOSPACH, Toni; NOSSAL, Robert et al.European journal of pediatrics. 2011, Vol 170, Num 10, pp 1337-1342, issn 0340-6199, 6 p.Article

Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammationROUHANI, Farshid N; MEITIN, Catherine A; KALER, Maryann et al.Respiratory medicine. 2005, Vol 99, Num 9, pp 1175-1182, issn 0954-6111, 8 p.Article

Sulfasalazine and pentoxifylline in psoriasis: A possible safe alternativeEL-MOFTY, Medhat; EL-DAROUTI, Mohamed; FAWZY, Marwa et al.Journal of dermatological treatment. 2011, Vol 22, Num 1, pp 31-37, issn 0954-6634, 7 p.Article

Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an updateLESO, Veruscka; LEGGIO, Lorenzo; ARMUZZI, Alessandro et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 7, pp 779-786, issn 0954-691X, 8 p.Article

TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, IschemiaReperfusion Injury and TraumaESPOSITO, E; CUZZOCREA, S.Current medicinal chemistry. 2009, Vol 16, Num 24, pp 3152-3167, issn 0929-8673, 16 p.Article

Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritisVAN DOORNUM, S; MCCOLL, G; WICKS, I. P et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 11, pp 1428-1432, issn 1462-0324, 5 p.Article

Can remission be maintained with or without further drug therapy in rheumatoid arthritis?SALEEM, B; NIZAM, S; EMERY, P et al.Clinical and experimental rheumatology (Testo stampato). 2006, Vol 24, Num 6, issn 0392-856X, S33-S36, SUP43Article

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic ReviewRAMON MANEIRO, Jose; SALGADO, Eva; GOMEZ-REINO, Juan J et al.Seminars in arthritis and rheumatism. 2012, Vol 42, Num 1, pp 89-103, issn 0049-0172, 15 p.Article

Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexateTORRANCE, G. W; TUGWELL, P; AMOROSI, S et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 6, pp 712-718, issn 1462-0324, 7 p.Article

Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasisBRAUN, Jürgen; RUDWALEIT, Martin; KARY, Sonja et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 8, pp 1578-1589, issn 1462-0324, 12 p.Article

Thromboembolic events and anti-tumor necrosis factor therapiesMASON, P. L.International immunopharmacology (Print). 2012, Vol 14, Num 4, pp 444-445, issn 1567-5769, 2 p.Article

Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab : The TOUCH trialKIVITZ, Alan; COHEN, Steven; DOWD, James Edward et al.Clinical therapeutics. 2006, Vol 28, Num 10, pp 1619-1629, issn 0149-2918, 11 p.Article

Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusionRUDWALEIT, Martin; OLIVIERI, Ignazio; BOKI, Kyriaki A et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 5, pp 551-557, issn 1462-0324, 7 p.Article

Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritisAMARI, Wassila; ZERINGUE, Angelique L; MCDONALD, Jay R et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 8, pp 1431-1439, issn 1462-0324, 9 p.Article

Anti-inflammatory response after infusion of p55 soluble tumor necrosis factor receptor fusion protein for severe sepsisBUTTY, Vincent L; ROUX-LOMBARD, Pascale; GARBINO, Jorge et al.European cytokine network (Montrouge). 2003, Vol 14, Num 1, pp 15-19, issn 1148-5493, 5 p.Article

Current and future pharmaceutical therapy for rheumatoid arthritisRUDERMAN, Eric M.Current pharmaceutical design. 2005, Vol 11, Num 5, pp 671-684, issn 1381-6128, 14 p.Article

Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United StatesANIS, Aslam H; BANSBACK, Nick; SIZTO, Sonia et al.Journal of dermatological treatment. 2011, Vol 22, Num 2, pp 65-74, issn 0954-6634, 10 p.Article

Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practiceBOMBARDIERI, S; RUIZ, A. A; FARDELLONE, P et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 7, pp 1191-1199, issn 1462-0324, 9 p.Article